3499 |
Modern Antegrade Approach in APCTO Algorithm |
Jong-Young Lee |
Apr. 28. 18 |
3498 |
Valve Thrombosis, Durability and Ongoing Antithrombotic Trials for TAVR |
Duk-Woo Park |
Apr. 28. 18 |
3497 |
Retrial CTO |
Satoru Otsuji |
Apr. 28. 18 |
3496 |
Long Segment CTO |
Toshiya Muramatsu |
Apr. 28. 18 |
3495 |
Heavy Calcific CTO |
Kambis Mashayekhi |
Apr. 28. 18 |
3494 |
REVASC: A Randomized Trial to Assess Recovery of Left Ventricular Function After PCI of Coronary Artery Chronic Total Occlusions |
Kambis Mashayekhi |
Apr. 28. 18 |
3493 |
Blunt Stump or Ambiguous Stump |
Jon Suh |
Apr. 28. 18 |
3492 |
HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-based DES with a Luminal CD34+ Antibody Coating Versus a Durable Polymer-based DES in Patients with Coronary Artery Disease |
Roxana Mehran |
Apr. 28. 18 |
3491 |
When the Retrograde Wire Won't Cross the Lesion |
Satoru Otsuji |
Apr. 28. 18 |
3490 |
ABSORB IV: 30-day Outcomes from a Randomized Trial of a Bioresorbable Scaffold Versus a Metallic DES in Patients with Coronary Artery Disease |
Gregg W. Stone |
Apr. 28. 18 |